New diabetes clinical trial: JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity

Published on: March 24, 2025 at 11:00PM
Conditions: Obesity (Disorder)
Interventions: Drug: Semaglutide Pen Injector; Behavioral: Behavioural Lifestyle Program (BLP)
Sponsors: McMaster University; Canadian Institutes of Health Research (CIHR); Diabetes Canada
Not yet recruiting
https://ift.tt/OPv8SI3